Salona Global Medical Device (TSE:EVMT) has released an update.
Evome Medical Technologies Inc. has partnered with irlabs for investor relations and communications services to enhance their market presence and shareholder value. The 12-month agreement with irlabs, which commences on July 1, 2024, includes a comprehensive investor relations program, with compensation set at a monthly fee starting at USD $5,000 and rising to USD $10,000 by January 2025. This strategic move aims to leverage Evome’s focus on human performance and rehabilitative medical solutions on a global scale.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
